ELISA Kit for Endothelial NOS (eNOS)

0.156-10ng/mL

The minimum detectable dose of this kit is typically less than 0.057ng/mL

3h

This assay has high sensitivity and excellent specificity for detection of Endothelial NOS (eNOS).
No significant cross-reactivity or interference between Endothelial NOS (eNOS) and analogues was observed.

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Endothelial NOS (eNOS). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Endothelial NOS (eNOS). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Endothelial NOS (eNOS), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Endothelial NOS (eNOS) in the samples is then determined by comparing the O.D. of the samples to the standard curve.

Inflammation influence on the formation of endothelial dysfunction in hypertensive patients caused by obesity; SIRT1 Gene Polymorphisms Affect the Protein Expression in Cardiovascular Diseases; Soluble Lectin-Like Oxidized LDL Receptor 1 as a Possible Mediator of Endothelial Dysfunction in Patients With Metabolic Syndrome; Chemerin plays a protective role by regulating human umbilical vein endothelial cell-induced nitric oxide signaling in preeclampsia; A Remarkable Age-Related Increase in SIRT1 Protein Expression against Oxidative Stress in Elderly:; Mutant DD genotype of NFKB1 gene is associated with the susceptibility and severity of coronary artery disease.; ThE REmOdELINg Of LEfT ATRIUm ANd vAsOdILATION fAcTORschANgEs IN IschEmIc hEART fAILURE; Endothelial nitric oxide synthase deficiency influences normal cell cycle progression andapoptosis in trabecular meshwork cells.; SIRT1 inhibits releases of HMGB1 and HSP70 from human umbilical vein endothelial cells caused by IL-6 and the serum from a preeclampsia patient and protects the cells from death.; SIRT1 inhibits releases of HMGB1 and HSP70 from human umbilical vein endothelial cells caused by IL-6 and the serum from a preeclampsia patient and protects the cells from death; THE INFLUENCE OF THE ADDITIONAL USAGE OF L-ARGININE ON THE FACTORS OF VASODILATION AND THE CLINICAL DATA, COMPLICATED WITH CARDIAC DECOMPENSATION WITH REDUCED AND PRESERVED FRACTURE OF THE LEFT VENTRICLE THAT PATIENTS WITH STABLE CORONARY HEART DISEASE HAVE; Blunted Nitric Oxide Regulation in Tibetans under High Altitude Hypoxia; Effect of statins on sirtuin 1 and endothelial nitric oxide synthase expression in young patients with a history of premature myocardial infarction; Stężenia śródbłonkowej i indukowalnej formy syntazy tlenku azotu w surowicy krwi kobiet ciężarnych palących tytoń–badania wstępne; Influence of Active Exposure to Tobacco Smoke on Nitric Oxide Status of Pregnant Women; Premature Myocardial Infarction: Genetic Variations in SIRT1 Affect Disease Susceptibility; Silica nanoparticles trigger the vascular endothelial dysfunction and prethrombotic state via miR-451 directly regulating the IL6R signaling pathway; Динамика показателей эндотелиальной дисфункции до и после операции у больных варикозной болезнью нижних конечностей;